Updates to our Terms of Use

We are updating our Terms of Use. Please carefully review the updated Terms before proceeding to our website.

Monday, July 15, 2024 | Back issues
Courthouse News Service Courthouse News Service

Shareholder Class Action

Shareholders challenge the $1.2 billion sale of Sucampo Pharmaceuticals to Mallinckrodt, for $18 a share, in a federal class action.

GREENBELT, Md. — Shareholders challenge the $1.2 billion sale of Sucampo Pharmaceuticals to Mallinckrodt, for $18 a share, in a federal class action.

Categories / Securities

Subscribe to Closing Arguments

Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.

Loading...